Francesca Orlandi
Colleretto Giacosa, 10010, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
The Balance Between the Therapeutic Efficacy and Safety of [177Lu]Lu-NeoB in a Preclinical Prostate Cancer Model.
Journal: Molecular imaging and biology
Published: May 16, 2023
In Vivo Biodistribution and Efficacy Evaluation of NeoB, a Radiotracer Targeted to GRPR, in Mice Bearing Gastrointestinal Stromal Tumor.
Journal: Cancers
Published: February 03, 2021
MITIGATE-NeoBOMB1, a Phase I/IIa Study to Evaluate Safety, Pharmacokinetics, and Preliminary Imaging of 68Ga-NeoBOMB1, a Gastrin-Releasing Peptide Receptor Antagonist, in GIST Patients.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: December 06, 2019
NeoBOMB1, a GRPR-Antagonist for Breast Cancer Theragnostics: First Results of a Preclinical Study with [67Ga]NeoBOMB1 in T-47D Cells and Tumor-Bearing Mice.
Journal: Molecules (Basel, Switzerland)
Published: October 26, 2017
Targeting Gastrointestinal Stromal Tumor with 68Ga-Labeled Peptides: An In Vitro Study on Gastrointestinal Stromal Tumor-Cell Lines.
Journal: Cancer biotherapy & radiopharmaceuticals
Published: October 19, 2016
68Ga/177Lu-NeoBOMB1, a Novel Radiolabeled GRPR Antagonist for Theranostic Use in Oncology.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: May 25, 2016
Erythropoietin Pretreatment of Transplanted Endothelial Colony-Forming Cells Enhances Recovery in a Cerebral Ischemia Model by Increasing Their Homing Ability: A SPECT/CT Study.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: December 03, 2015
Showing 1-8 of 8
Last Updated: 09/26/2026